Journal of Cancer Research and Clinical Oncology

, Volume 136, Issue 7, pp 975–979

MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 Subjects

Original Paper

DOI: 10.1007/s00432-009-0742-x

Cite this article as:
Mao, C., Qiu, LX., Zhan, P. et al. J Cancer Res Clin Oncol (2010) 136: 975. doi:10.1007/s00432-009-0742-x



Published data on the association between manganese superoxide dismutase (MnSOD) Val16Ala polymorphism and prostate cancer (PCA) risk are inconclusive. To derive a more precise estimate of the association between them, a meta-analysis was performed.


PubMed and Embase were searched. All eligible studies were retrieved. The pooled odds ratio (OR) with 95% confidence interval (CI) for PCA risk associated with Val/Ala versus Val/Val, Ala/Ala versus Val/Val, dominant model (Ala/Ala + Val/Ala vs. Val/Val), and recessive model (Ala/Ala vs. Val/Ala + Val/Val) were estimated, respectively.


A total of 12 studies including 8,962 subjects were involved in this meta-analysis. Overall, the meta-analysis indicated that significantly elevated cancer risk was associated with Ala variant genotype when all the eligible studies were pooled into the meta-analysis (for Val/Ala vs. Val/Val: OR = 1.11, 95% CI = 1.00–1.24; for Ala/Ala vs. Val/Val: OR = 1.22, 95% CI = 1.00–1.49; for dominant model: OR = 1.14, 95% CI = 1.03–1.26). In the subgroup analysis by ethnicity, statistically significant increased risks were found among Caucasians with Ala allele (for Val/Ala vs. Val/Val: OR = 1.12, 95% CI = 1.00–1.25; for dominant model: OR = 1.14, 95% CI = 1.02–1.26). However, no significant associations were found in Africans.


This meta-analysis suggests that the Ala allele of the MnSOD gene was a low-penetrance susceptible gene in PCA development, especially in Caucasians.


MnSODPolymorphismProstate cancerSusceptibilityMeta-analysis

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Department of Epidemiology, School of Public Health and Tropical MedicineSouthern Medical UniversityGuangzhouChina
  2. 2.Department of Medical Oncology, Cancer HospitalFudan UniversityShanghaiPeople’s Republic of China
  3. 3.Department of Oncology, Shanghai Medical CollegeFudan UniversityShanghaiChina
  4. 4.Department of Respiratory MedicineNanjing Chest HospitalNanjingChina
  5. 5.Longgang Center for Disease Control and Prevention of ShenzhenShenzhenChina
  6. 6.Department of Respiratory MedicineHefei Second People’s HospitalHefeiChina